AI assistant
Median Technologies — Share Issue/Capital Change 2021
Apr 13, 2021
1514_dva_2021-04-13_c5bd3c93-3f0f-4606-8a5c-d12304fbfe30.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Press release – For immediate release April 13th, 2021 – 05:45pm CEST
Disclosure of total number of voting rights and number of shares in the capital as of March 31st , 2021
Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Sophia Antipolis, France
| Total number of shares | 14,677,710 |
|---|---|
| Number of real voting rights (excluding treasury shares*) |
14,623,319 |
| Theoritical number of voting rights (including treasury shares*) |
14,654,510 |
(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF's General Regulations
About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment strategies. Our unique solutions for medical image analysis and management in oncology trials and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors
and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label "Innovative company" by the BPI France and is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME), is listed on the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com
Contacts
| Median Technologies | Press - ALIZE RP | Investors - ACTIFIN |
|---|---|---|
| Emmanuelle Leygues | Caroline Carmagnol | Ghislaine Gasparetto |
| Head of Corporate and Marketing Communications | +33 6 64 18 99 59 | +33 1 56 88 11 11 |
| +33 6 10 93 58 88 | [email protected] | [email protected] |
| [email protected] |